Susanne Lezius

Susanne Lezius

Auto-generated profile, based on publicly available information

Susanne Lezius

Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, null, Germany

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
DSDoreen Schreiber
Doreen Schreiber
TRThomas Rostock
Thomas Rostock
MFMax Fröhlich
Max Fröhlich
ASArian Sultan
Arian Sultan
HSHelge Servatius
Helge Servatius
DSDaniel Steven
Daniel Steven
Background—: In the meantime, catheter ablation is widely used for the treatment of persistent atrial fibrillation (AF). There is a paucity of data about long-term outcomes. This study evaluates (1) 5-year single and multiple procedure success and (2) prognostic factors for arrhythmia recurrences after catheter ablation of persistent AF using the stepwise approach aiming at AF termination. Methods and Results—: A total of 549 patients with persistent AF underwent de novo catheter ablation using the stepwise approach (2007–2009). A total of 493 patients were included (Holter ECGs ≥every 6 months). Mean follow-up was 59±16 months with 2.1±1.1 procedures per patient. Single and multiple procedure success rates were 20.1% and 55.9%, respectively (80% off antiarrhythmic drug). Antiarrhythmic drug–free multiple procedure success was 46%. Long-term recurrences (n=171) were paroxysmal AF in 48 patients (28%) and persistent AF/atrial tachycardia in 123 patients (72%). Multivariable recurrent event analysis revealed the following factors favoring arrhythmia recurrence: failure to terminate AF during index procedure (hazard ratio [HR], 1.279; 95% confidence interval [CI], 1.093–1.497; P =0.002), number of procedures (HR, 1.154; 95% CI, 1.051–1.267; P =0.003), female sex (HR, 1.263; 95% CI, 1.027–1.553; P =0.027), and the presence of structural heart disease (HR, 1.236; 95% CI, 1.003–1.524; P =0.047). AF termination was correlated with a higher rate of consecutive procedures because of atrial tachycardia recurrences ( P =0.003; HR, 1.71; 95% CI, 1.20–2.43). Conclusions—: Catheter ablation of persistent AF using the stepwise approach provides limited long-term freedom of arrhythmias often requiring multiple procedures. AF termination, the number of procedures, sex, and the presence of structural heart disease correlate with outcome success. AF termination is associated with consecutive atrial tachycardia procedures.

6 February 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SBSophia Bergmann
Sophia Bergmann
BBBarbara von Buenau
Barbara von Buenau
SVSabine Vidal-Y-Sy
Sabine Vidal-Y-Sy
MHMarek Haftek
Marek Haftek
EWEwa Wladykowski
Ewa Wladykowski
JBJohanna M. Brandner
Johanna M. Brandner
The transmembrane protein claudin-1 is a major component of epidermal tight junctions (TJs), which create a dynamic paracellular barrier in the epidermis. Claudin-1 downregulation has been linked to atopic dermatitis (AD) pathogenesis but variable levels of claudin-1 have also been observed in healthy skin. To elucidate the impact of different levels of claudin-1 in healthy and diseased skin we determined claudin-1 levels in AD patients and controls and correlated them to TJ and skin barrier function. We observed a strikingly broad range of claudin-1 levels with stable TJ and overall skin barrier function in healthy and non-lesional skin. However, a significant decrease in TJ barrier function was detected in lesional AD skin where claudin-1 levels were further reduced. Investigations on reconstructed human epidermis expressing different levels of claudin-1 revealed that claudin-1 levels correlated with inside-out and outside-in barrier function, with a higher coherence for smaller molecular tracers. Claudin-1 decrease induced keratinocyte-autonomous IL-1β expression and fostered inflammatory epidermal responses to non-pathogenic Staphylococci. In conclusion, claudin-1 decrease beyond a threshold level results in TJ and epidermal barrier function impairment and induces inflammation in human epidermis. Increasing claudin-1 levels might improve barrier function and decrease inflammation and therefore be a target for AD treatment.

1 August 2018 in The Lancet Child & Adolescent Health
Verified
Journal Article
Closed access
MNMiriam Nickel
Miriam Nickel
ASAlessandro Simonati
Alessandro Simonati
DJDavid Jacoby
David Jacoby
SLSusanne Lezius
Susanne Lezius
DKDirk Kilian
Dirk Kilian
ASAngela Schulz
Angela Schulz

15 August 2016 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
ADAnke Diemert
Anke Diemert
SLSusanne Lezius
Susanne Lezius
MPMirja Pagenkemper
Mirja Pagenkemper
GHGudula Hansen
Gudula Hansen
ADAlina Drozdowska
Alina Drozdowska
BZBirgit-Christiane Zyriax
Birgit-Christiane Zyriax
The aim of our study was to examine maternal weight gain as well as nutrient intake in pregnancy throughout each trimester compared to current recommendations in a low-risk population and its correlation to birth weight. Additionally, we have investigated the association of maternal nutrition with gestational weight gain and birth weight in an economically unrestricted population. Our analysis was carried out in a population-based prospective birth cohort in Hamburg, Germany. 200 pregnant women and 197 infants born at term were included in the analysis. Maternal body weight, weight gain throughout gestation, and birth weight, macro- and micronutrients were assessed based on a 24 h dietary recall in each trimester. Our main outcome measures were weight gain, birth weight, and self-reported dietary intake in each trimester in comparison to current recommendations. One third of the women were characterized by an elevated pre-pregnancy BMI, 60 % did not comply with current weight gain recommendations. Particularly overweight and obese women gained more weight than recommended. In a multivariate analysis birth weight correlated significantly with maternal BMI (p = 0.020), total weight gain (p = 0.020) and gestational week (p < 0.001). Compared to guidelines mean percentage of energy derived from fat (p = 0.002) and protein (p < 0.001) was significantly higher, whereas carbohydrate (p = 0.033) intake was lower. Mean fiber intake was significantly lower (p < 0.001). Saturated fat and sugar contributed largely to energy consumption. Gestational weight gain correlated significantly with energy (p = 0.027), carbohydrates (p = 0.008), monosaccharides and saccharose (p = 0.006) intake. 98 % of the pregnant women were below the iodine recommendation, while none of the women reached the required folate, vitamin D, and iron intake. During gestation appropriate individual advice as to nutrient intake and weight gain seems to be of high priority. Pregnancy should be used as a ‘window of opportunity’ for behavioral changes.

5 February 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
ABAnna Both
Anna Both
JHJiabin Huang
Jiabin Huang
MQMinyue Qi
Minyue Qi
CLChristian Lausmann
Christian Lausmann
SWSamira Weißelberg
Samira Weißelberg
HRHolger Rohde
Holger Rohde
S.epidermidisis a substantial component of the human skin microbiota, but also one of the major causes of nosocomial infection in the context of implanted medical devices. We here aimed to advance the understanding ofS.epidermidisgenotypes and phenotypes conducive to infection establishment. Furthermore, we investigate the adaptation of individual clonal lines to the infection lifestyle based on the detailed analysis of individualS.epidermidispopulations of 23 patients suffering from prosthetic joint infection. Analysis of invasive and colonizingS.epidermidisprovided evidence that invasiveS.epidermidisare characterized by infection-supporting phenotypes (e.g. increased biofilm formation, growth in nutrient poor media and antibiotic resistance), as well as specific genetic traits. The discriminating gene loci were almost exclusively assigned to the mobilome. Here, in addition to IS256and SCCmec, chromosomally integrated phages was identified for the first time. These phenotypic and genotypic features were more likely present in isolates belonging to sequence type (ST) 2. By comparing seven patient-matched nasal and invasiveS.epidermidisisolates belonging to identical genetic lineages, infection-associated phenotypic and genotypic changes were documented. Besides increased biofilm production, the invasive isolates were characterized by better growth in nutrient-poor media and reduced hemolysis. By examining several colonies grown in parallel from each infection, evidence for genetic within-host population heterogeneity was obtained. Importantly, subpopulations carrying IS insertions inagrC, mutations in the acetate kinase (AckA) and deletions in the SCCmecelement emerged in several infections. In summary, these results shed light on the multifactorial processes of infection adaptation and demonstrate howS.epidermidisis able to flexibly repurpose and edit factors important for colonization to facilitate survival in hostile infection environments.

30 November 2017 in European Journal of Heart Failure
Verified
Journal Article
Open access
PDF file
MCMartin R. Cowie
Martin R. Cowie
HWHolger Woehrle
Holger Woehrle
KWKarl Wegscheider
Karl Wegscheider
EVEik Vettorazzi
Eik Vettorazzi
SLSusanne Lezius
Susanne Lezius
HTHelmut Teschler
Helmut Teschler
Aims: The SERVE-HF trial investigated the impact of treating central sleep apnoea (CSA) with adaptive servo-ventilation (ASV) in patients with systolic heart failure. A preplanned substudy was conducted to provide insight into mechanistic changes underlying the observed effects of ASV, including assessment of changes in left ventricular function, ventricular remodelling, and cardiac, renal and inflammatory biomarkers. Methods and results: In a subset of the 1325 randomised patients, echocardiography, cardiac magnetic resonance imaging (cMRI) and biomarker analysis were performed at baseline, and 3 and 12 months. In secondary analyses, data for patients with baseline and 12-month values were evaluated; 312 patients participated in the substudy. The primary endpoint, change in echocardiographically determined left ventricular ejection fraction from baseline to 12 months, did not differ significantly between the ASV and the control groups. There were also no significant between-group differences for changes in left ventricular dimensions, wall thickness, diastolic function or right ventricular dimensions and ejection fraction (echocardiography), and on cMRI (in small patient numbers). Plasma N-terminal pro B-type natriuretic peptide concentration decreased in both groups, and values were similar at 12 months. There were no significant between-group differences in changes in cardiac, renal and systemic inflammation biomarkers. Conclusion: In patients with systolic heart failure and CSA, addition of ASV to guideline-based medical management had no statistically significant effect on cardiac structure and function, or on cardiac biomarkers, renal function and systemic inflammation over 12 months. The increased cardiovascular mortality reported in SERVE-HF may not be related to adverse remodelling or worsening heart failure.